Citius Pharmaceuticals, Inc. Derivative Liability
Citius Pharmaceuticals, Inc. (CTXR) had Derivative Liability of $581.16 thousand as of 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2017-08-14
- 2017-06-30: Derivative Liability $581.16K.
- 2017-03-31: Derivative Liability $426.26K.
- 2016-12-31: Derivative Liability $910.58K.
- 2016-09-30: Derivative Liability $1.68M.
| Period end | Derivative Liability |
|---|---|
| 2017-06-30 | $581.16K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $426.26K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $910.58K 10-Q · filed 2017-02-14 |
| 2016-09-30 | $1.68M 10-Q · filed 2017-08-14 |
| 2016-06-30 | $2.95M 10-Q · filed 2017-08-14 |
| 2016-03-31 | $1.50M 10-Q · filed 2017-05-15 |
| 2015-12-31 | $873.00K 10-Q · filed 2017-02-14 |
| 2015-09-30 | $738.96K 10-Q · filed 2017-08-14 |
| 2015-06-30 | $1.72M 10-Q · filed 2016-08-15 |
| 2015-03-31 | $1.25M 10-Q · filed 2016-05-20 |
| 2014-12-31 | $1.39M 10-Q · filed 2016-02-12 |
| 2014-09-30 | $1.45M 10-K · filed 2016-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |